5,7-dimethoxycoumarin has been researched along with roflumilast in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hou, KQ; Huang, Y; Huang, YY; Liu, L; Luo, HB; Song, Z; Wan, G; Xiong, XF; Zhou, F | 1 |
1 other study(ies) available for 5,7-dimethoxycoumarin and roflumilast
| Article | Year |
|---|---|
Discovery and Structural Optimization of Toddacoumalone Derivatives as Novel PDE4 Inhibitors for the Topical Treatment of Psoriasis.
Topics: Administration, Topical; Animals; Cyclic Nucleotide Phosphodiesterases, Type 4; Mice; Phosphodiesterase 4 Inhibitors; Psoriasis; Skin | 2022 |